跳至主要内容
临床试验/ISRCTN48462333
ISRCTN48462333已完成不适用

Tolerance and safety study of a new paediatric peptide feed

umico Research B.V. (Netherlands)0 个研究点目标入组 24 人开始时间: 2006年1月27日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children requiring a paediatric peptide feed. Some conditions where this is required may include inflammatory bowel disease, short bowel syndrome, pancreas/liver disease, chronic diarrhoea, cystic fibrosis, undiagnosed gut problems, coeliac disease.
  • 2. Approximately 8 - 30 kg in weight
  • 3. Peptide based feed prescribed for at least 50% of daily energy requirements
  • 4. Expected need of peptide based feed for a minimum of 2 months
  • 5. Written parental informed consent

排除标准

  • 1. Infants under 1 year of age
  • 2. Children receiving parenteral nutrition for more than 50% energy requirements
  • 3. Children with galactosaemia
  • 4. Children with cow milk allergy
  • 5. Children with medical or dietary contraindication
  • 6. If the investigator is, for any reason, uncertain about the willingness to comply with the protocol requirements, the subject can be excluded
  • 7. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • 8. Multiple allergies

研究者

发起方
umico Research B.V. (Netherlands)

相似试验